Jacobs Engineering Group
J
$145.06
-0.82%
Jacobs Solutions Inc. is a global professional services firm delivering engineering, design, procurement, construction management, and cyber/security solutions to industrial, commercial, and government clients across water, transportation, healthcare, technology, and chemicals end markets, generating roughly $12 billion in fiscal 2025 revenue with approximately 43,000-60,000 employees. The company is a scaled, relationship-driven incumbent in the Engineering & Construction sector, distinguished by a consulting-heavy, asset-light model and a large public-sector backlog that differentiates it from capital-intensive contractors, with its Infrastructure & Advanced Facilities segment ($3.75 billion) dwarfing the smaller PA Consulting strategic advisory arm ($330 million). The current investor narrative centers on a sharp growth reacceleration — Q3 fiscal 2026 revenue rose 34.6% year over year to $4.08 billion — alongside a volatile earnings profile (a Q2 GAAP loss of $45.9 million followed by a Q3 rebound to $136.6 million net income) that has kept the stock range-bound and left it lagging the broader market over the past year. Debate now hinges on whether the revenue surge reflects durable backlog conversion and margin recovery or acquisition/working-capital-driven distortion, with the elevated trailing PE and depressed trailing EPS amplifying the importance of forward earnings delivery.…
J
Jacobs Engineering Group
$145.06
Investment Opinion: Should I buy J Today?
Rating: Hold with a constructive bias. The core thesis is that Jacobs is a fairly valued, low-beta engineering consultancy whose 34.57% Q3 revenue growth and 17.13x forward PE offer reasonable upside if margin recovery materializes, but whose 19.89% gross margin and $0.016 trailing EPS leave too little evidence to justify a full Buy. The analyst consensus of 1.94 (buy) with an average target of $162.33 (+15.1% upside) supports patience rather than aggressive accumulation.
Supporting evidence is mixed but leans positive on valuation: forward PE of 17.13x is in line to modestly below the high-teens to low-20s peer range, EV/Sales of 1.37x and PS of 1.48x sit near the bottom of the stock's 2.95x-5.66x historical band, and trailing free cash flow of $644.5 million funds both the $142.2 million Q3 buyback and the 0.86% dividend at a 52.7% payout ratio. Revenue growth of 34.57% year over year is clearly strong, and the $11.60 billion consensus revenue estimate implies continuation. However, the 2.41% net margin, 7.18% operating margin, and 7.97% ROE are all below what higher-quality peers deliver, which justifies the valuation discount rather than signaling mispricing.
The biggest risks are continued gross-margin compression below 19%, a repeat of the Q2 working-capital drain, and failure to deliver the $11.43 forward EPS. This Hold would upgrade to Buy if gross margin stabilizes above 22% for two consecutive quarters or if the stock pulls back toward $125 (implying roughly 11x forward EPS), and it would downgrade to Sell if gross margin falls below 18% or forward EPS estimates drop toward the $10.11 low. On balance the stock looks fairly valued relative to its own history and peers — not overvalued, but not yet the discount the forward multiple superficially suggests.
Sign up to view all
J 12-Month Price Forecast
The forward-looking view is balanced: the stock is fairly valued at 17.13x forward earnings with a 15.1% consensus upside, but the entire thesis hinges on margin recovery that has not yet appeared. Revenue growth of 34.57% is impressive, yet gross margin has fallen roughly 440bp in three quarters, and the $0.016 trailing EPS makes current profitability essentially unverifiable. The low beta of 0.698 and the analyst low target of $144.00 above the current price limit downside, while the $181 high target caps realistic upside near +28%. I would upgrade to bullish if gross margin prints above 22% for two consecutive quarters or if forward EPS estimates rise above $12, and I would downgrade to bearish if gross margin falls below 18% or the stock breaks below the $135 late-September floor.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jacobs Engineering Group's 12-month outlook, with a consensus price target around $162.33 and implied upside of +11.9% versus the current price.
Average Target
$162.33
0 analysts
Implied Upside
+11.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$144 - $181
Analyst target range
Coverage is solid with 15 analysts and a consensus recommendation of "buy" (mean rating 1.94 on a 1-5 scale where lower is more bullish), and the average target price of $162.33 implies roughly +15.1% upside from the current $141.08 — a constructive but not euphoric signal that leans bullish without pricing in a full re-rating. The consensus EPS estimate of $11.43 (range $10.11-$12.29) and revenue estimate of $11.60 billion are consistent with the forward PE of 17.1x, meaning the bullish case rests on earnings delivery rather than multiple expansion. Institutional ratings show stability rather than momentum: UBS reiterated Buy on August 10, 2026, RBC Capital reiterated Outperform on August 5 and July 22, Citigroup maintained Buy on May 6, while Truist and Wells Fargo stayed at Hold/Equal Weight — a pattern of conviction among bulls with persistent holdouts on margin concerns. The target range of $144.00 to $181.00 is moderately wide (the high is about 25.7% above the low), with even the low target above the current price, implying analysts see the stock as undervalued at $141; the $181 high assumes margin recovery toward historical levels plus multiple expansion on backlog conversion, while the $144 low prices in continued gross-margin compression (already down to 19.89% in Q3) and limited earnings leverage. The tight clustering of the low target just 2.1% above the current price suggests limited downside conviction, but the wide high-to-low spread signals genuine uncertainty about the pace of the margin turnaround.
Bulls vs Bears: J Investment Factors
The bear case currently has stronger hard evidence: gross margin has compressed roughly 440bp in three quarters to 19.89%, trailing EPS is $0.016, and the stock has lagged SPY by 25.13% over a year. The bull case rests on forward expectations — 34.57% revenue growth, a 17.13x forward PE, and a $162.33 consensus target implying 15.1% upside — rather than realized profitability. The single most important tension is whether the revenue surge converts into margin recovery: if gross margin stabilizes and forward EPS of $11.43 materializes, the stock is cheap; if compression continues, the forward multiple is illusory. Analyst conviction (mean 1.94, low target above the current price) leans bullish, but the wide $144-$181 target range signals genuine uncertainty about the pace of that turnaround.
Bullish
- Revenue reaccelerating sharply: Q3 fiscal 2026 revenue of $4.076 billion grew 34.57% year over year versus $3.029 billion a year ago, and rose sequentially from $3.695 billion in Q2 and $3.293 billion in Q1. The consensus revenue estimate of $11.60 billion implies this top-line expansion continues, underpinning the growth case.
- Forward valuation not demanding: The forward PE of 17.13x on consensus EPS of $11.43 is roughly in line to modestly below the high-teens to low-20s typical of engineering & construction peers. EV/Sales of 1.37x and PS of 1.48x sit near the bottom of the stock's own historical 2.95x-5.66x PS band.
- Analyst consensus skewed bullish: 15 analysts carry a mean rating of 1.94 (buy) with an average target of $162.33, implying +15.1% upside from $141.08. Even the low target of $144.00 sits 2.1% above the current price, meaning no covering analyst models downside from here.
- Solid free cash flow and shareholder returns: Trailing free cash flow is $644.5 million (FCF per share of $3.63) with Q3 operating cash flow of $456.1 million. The company funded $142.2 million of Q3 buybacks plus $42.2 million of dividends internally, and the 0.86% yield is covered at a 52.7% payout ratio.
Bearish
- Gross margin compression is severe: Gross margin has fallen from 24.31% in Q4 fiscal 2025 to 21.51% in Q2 and 19.89% in Q3 fiscal 2026, a roughly 440bp decline in three quarters. The 7.18% operating margin and 2.41% net margin are well below what scaled engineering consultancies typically earn.
- Earnings volatility and near-zero trailing EPS: A Q2 GAAP loss of $45.9 million (EPS -$0.34) was followed by Q3 net income of $136.6 million, and trailing EPS is just $0.016. The 61.87x trailing PE and negative PEG of -0.99 are artifacts of this depressed base, so the entire thesis rests on forward earnings delivery.
- Revenue surge may be low-quality: The roughly $381 million Q2-to-Q3 revenue jump alongside falling gross margin suggests mix shift toward lower-margin pass-through or acquisition content rather than organic consulting growth. Q2 also burned $484.1 million of operating cash on a $501.1 million working-capital swing, showing cash conversion is seasonal and backlog-dependent.
- Persistent underperformance versus market: The stock is down 9.60% over the past year against SPY's +15.53%, a -25.13% relative-strength gap, and remains 16.2% below its 52-week high with a 34.77% max drawdown. The 1-month change of -1.68% versus SPY's +1.22% shows the recovery has stalled recently.
J Technical Analysis
Jacobs is in a recovery phase within a broader range-bound structure: the stock is down 9.60% over the past year versus a 15.53% gain for SPY (a -25.13% relative-strength gap), yet it has rebounded 9.42% over six months and 4.23% year to date. At $141.08, the shares sit at roughly 56% of the 52-week range between the $105.68 low and $168.44 high — above the midpoint but still 16.2% below the high, which reads as constructive repair rather than momentum overextension, with the 34.77% max drawdown underscoring how much ground was surrendered earlier in the cycle. Recent momentum is mixed but improving: the 3-month change of +7.08% and 6-month change of +9.42% contrast with a 1-month decline of -1.68%, a divergence that looks like a healthy consolidation after the August run to $151.98 rather than a trend reversal, especially since the 1-month relative strength of -2.90% versus SPY's +1.22% reflects profit-taking rather than distribution. The stock has stabilized in the $135-$142 zone since late September, and with beta of just 0.698 the name moves roughly 30% less than the market, favoring smaller position-sizing adjustments and a lower volatility premium in risk models. Key resistance sits at the August high near $151.98 and then the 52-week high of $168.44; a decisive break above $152 would confirm a new uptrend leg and open the path toward the high, while a breakdown below the $135 area (the late-September floor) would expose the $105.68 52-week low and signal failed recovery. Volume of roughly 1.01 million shares and a short ratio of 4.88 days suggest moderate but not extreme bearish positioning, leaving room for a squeeze on upside breakouts.
Beta
0.70
0.70x market volatility
Max Drawdown
-34.8%
Largest decline past year
52-Week Range
$106-$168
Price range past year
Annual Return
-9.8%
Cumulative gain past year
| Period | J Return | S&P 500 |
|---|---|---|
| 1m | +2.8% | -1.0% |
| 3m | +7.8% | +2.9% |
| 6m | +14.6% | +6.5% |
| 1y | -9.8% | +13.1% |
| ytd | +7.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
J Fundamental Analysis
Revenue is clearly reaccelerating: Q3 fiscal 2026 revenue of $4.076 billion grew 34.57% year over year versus $3.029 billion in the year-ago quarter, and rose sequentially from $3.695 billion in Q2 and $3.293 billion in Q1, with the Infrastructure & Advanced Facilities segment at $3.747 billion driving the bulk of the top line while PA Consulting contributes $330 million. The trajectory is strong but lumpy — the Q2-to-Q3 jump of roughly $381 million in a single quarter warrants scrutiny for acquisition or pass-through content — and the analyst consensus revenue estimate of $11.60 billion (range $10.57-$12.28 billion) implies continued top-line expansion that underpins the growth case. Profitability is the weak link: Q3 net income of $136.6 million (3.35% net margin) followed a Q2 loss of $45.9 million, and gross margin has compressed from 24.31% in Q4 fiscal 2025 to 21.51% in Q2 and 19.89% in Q3 fiscal 2026, while the trailing operating margin of 7.18% and net margin of 2.41% sit well below the 24.81% gross margin level and below what scaled engineering consultancies typically earn. The margin compression alongside revenue growth suggests mix shift toward lower-margin pass-through work or cost inflation, and the trailing EPS of just $0.016 versus the forward estimate of $11.43 highlights how depressed and volatile reported earnings remain. The balance sheet is serviceable but not fortress-like: debt-to-equity of 0.744, current ratio of 1.30, and cash of $1.19 billion against $505 million of Q3 debt repayment, with trailing free cash flow of $644.5 million (FCF per share of $3.63) and Q3 operating cash flow of $456.1 million — though Q2 burned $484.1 million of operating cash on a $501.1 million working-capital swing, showing cash generation is seasonal and backlog-dependent. ROE of 7.97% and ROA of 4.55% are modest, the 0.86% dividend yield with a 52.7% payout ratio is well covered, and the $142.2 million of Q3 buybacks plus $42.2 million of dividends confirm the company can fund returns internally, but the reliance on working-capital timing means external financing risk is low yet not negligible.
Quarterly Revenue
$4.1B
2026-06
Revenue YoY Growth
+34.6%
YoY Comparison
Gross Margin
19.9%
Latest Quarter
Free Cash Flow
$644544000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is J Overvalued?
Because trailing net income is positive but negligible (EPS of $0.016), the trailing PE of 61.87x is economically meaningless and I therefore lead with the forward PE of 17.13x, cross-checked against EV/EBITDA of 20.75x and EV/Sales of 1.37x; the enormous gap between trailing (61.87x) and forward (17.13x) multiples implies the market expects a dramatic earnings normalization toward the $11.43 consensus EPS, a bet that hinges on margin recovery rather than revenue alone. On sales, the 1.48x PS and 1.37x EV/Sales are modest for an engineering and consulting franchise, but the 20.75x EV/EBITDA and 25.86x price-to-cash-flow reflect the currently depressed EBITDA base (Q2 EBITDA was negative $33.3 million), so the headline multiples overstate cheapness on an earnings basis. Against a typical Industrials/Engineering & Construction peer set trading in the high-teens to low-20s forward PE, Jacobs' 17.1x forward multiple is roughly in line to modestly below sector, a discount that appears justified by the 2.41% net margin, 7.18% operating margin, and 7.97% ROE — all below what higher-quality peers deliver — rather than by superior growth. Historically, Jacobs' own PE has ranged from roughly 12.8x (Q4 2024) to over 60x in loss-distorted quarters, with the PS ratio spanning about 2.95x to 5.66x; the current 1.48x PS sits near the bottom of that band while the 4.88x price-to-book is near the top, a mixed signal suggesting the market is pricing modest sales expectations but paying up for book value and recovery optionality. The negative PEG ratio of -0.99 is a mechanical artifact of the near-zero trailing EPS and should be disregarded; on balance, valuation looks fair-to-attractive only if forward earnings materialize, leaving limited margin of safety if margins stay compressed.
PE
61.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin erosion and earnings quality. Gross margin has fallen from 24.31% in Q4 fiscal 2025 to 19.89% in Q3 fiscal 2026, and the 7.18% operating margin leaves little buffer if pass-through mix keeps rising. Earnings are highly volatile — a Q2 loss of $45.9 million followed by Q3 net income of $136.6 million — and trailing EPS of $0.016 means the 61.87x trailing PE is meaningless, so the 17.13x forward PE depends entirely on delivering $11.43 of EPS. Cash generation is also lumpy: Q2 burned $484.1 million of operating cash on a $501.1 million working-capital swing, and debt-to-equity of 0.744 with a 1.30 current ratio offers only moderate financial flexibility.
Market and competitive risks stem from valuation sensitivity and relative underperformance. The stock trades at 20.75x EV/EBITDA and 25.86x price-to-cash-flow on a depressed EBITDA base (Q2 EBITDA was negative $33.3 million), so any disappointment in margin recovery would compress multiples quickly. Beta of 0.698 dampens market-wide moves but does not protect against sector-specific derating, and the -25.13% one-year relative-strength gap versus SPY shows the market has already been repricing the name. The 4.88x price-to-book near the top of its historical band, against a 1.48x PS near the bottom, signals the market is paying for recovery optionality rather than current earnings, leaving little cushion if the turnaround stalls.
The worst-case scenario is a renewed margin breakdown combined with a working-capital squeeze: if Q4 gross margin falls below 19% and forward EPS guidance drifts toward the $10.11 low estimate, the forward PE would re-rate toward the low end of its historical 12.8x band, implying a price near $130. A deeper derating toward the $105.68 52-week low would represent roughly -25% from $141.08, and the 34.77% max drawdown shows the stock has already demonstrated that magnitude of loss. The analyst low target of $144.00 caps modeled downside at the consensus level, but the stock's own trading history suggests a -25% to -35% drawdown is a realistic adverse outcome if the earnings normalization fails to materialize.
FAQ
The most severe risk is margin compression: gross margin has fallen from 24.31% to 19.89% in three quarters, and the 7.18% operating margin leaves little buffer, directly threatening the $11.43 forward EPS. Second is earnings and cash-flow volatility, evidenced by the Q2 loss of $45.9 million and the $484.1 million Q2 operating cash burn on a $501.1 million working-capital swing. Third is valuation derating risk, since 20.75x EV/EBITDA and 25.86x price-to-cash-flow rest on a depressed EBITDA base and would compress quickly on disappointment. Fourth is relative underperformance and leverage, with a -25.13% one-year gap versus SPY and debt-to-equity of 0.744 limiting financial flexibility.
The base case (50% probability) targets $150-$165, assuming forward EPS near $11.43 and gross margin stabilizing in the 20-22% range, consistent with the $162.33 average analyst target. The bull case (25%) targets $168-$181 if gross margin recovers above 22% and EPS approaches the $12.29 high estimate, aligning with the $181 analyst high. The bear case (25%) targets $106-$130 if gross margin breaks below 19% and EPS drifts toward $10.11, pulling the stock toward the $105.68 52-week low. The base case is most likely, and its key assumption is that the 34.57% revenue growth converts into stable rather than deteriorating margins.
The headline 61.87x trailing PE is economically meaningless given $0.016 trailing EPS, so the relevant metric is the 17.13x forward PE on $11.43 consensus EPS, which is in line to modestly below the high-teens to low-20s peer range. On sales, the 1.48x PS and 1.37x EV/Sales sit near the bottom of the stock's historical 2.95x-5.66x PS band, while the 4.88x price-to-book is near the top — a mixed signal. The 20.75x EV/EBITDA and 25.86x price-to-cash-flow look expensive only because EBITDA is depressed (Q2 was negative $33.3 million). The market is pricing modest sales expectations but paying up for recovery optionality, implying it expects margin normalization rather than revenue alone to drive earnings.
From a risk/reward perspective, J offers roughly 15.1% upside to the $162.33 average analyst target against limited modeled downside, since even the $144.00 low target sits 2.1% above the $141.08 price. The 17.13x forward PE is reasonable for an engineering consultancy, and the 0.698 beta means the position adds below-market volatility. However, the biggest downside risk is that gross margin keeps compressing from 19.89%, which would invalidate the $11.43 forward EPS and expose the $105.68 52-week low, roughly -25%. It is a reasonable buy for patient, income-tolerant investors comfortable with a 12-month horizon, but not for those seeking near-term momentum given the -1.68% one-month change.
J is better suited to a medium-to-long-term holding period of at least 12 months, given that the thesis depends on margin recovery that has not yet appeared in reported results. The 0.698 beta and 0.86% dividend yield with a 52.7% payout ratio make it a lower-volatility, income-tolerant position rather than a trading vehicle. Short-term traders face a stock that is -1.68% over one month and range-bound between $135 and $142 since late September, offering limited momentum. Earnings visibility is clouded by the swing from a Q2 loss of $45.9 million to Q3 net income of $136.6 million, so investors should allow multiple quarters for the forward EPS of $11.43 to be validated before judging the position.